The second quarter of 2022 saw mixed market sentiments for titanium dioxide prices. Due to demands, constrained supply and ineffective production capacity brought on by the stretched supply chain, labour shortage, and high energy prices, the production of the chemical increased in Q2 of 2022. Moreover, the US Federal Reserve's tight monetary policy and high interest rates worsened the domestic trade picture, which at quarter's conclusion supported titanium dioxide's unfavourable market views.

In a 2020 study published in the Journal of Trace Elements in Medicine and Biology, researchers conducted an in vitro experiment to analyze the effects of TiO2 nanoparticles on a human neuroblastoma (SH-SY5Y) cell line. The scientists evaluated “reactive oxygen species (ROS) generation, apoptosis, cellular antioxidant response, endoplasmic reticulum stress and autophagy.” The results showed that exposure to the nanoparticles “induced ROS generation in a dose dependent manner, with values reaching up to 10 fold those of controls. Nrf2 nuclear localization and autophagy also increased in a dose dependent manner. Apoptosis increased by 4- to 10-fold compared to the control group, depending on the dose employed.”